Drugs that contain Acyclovir; Hydrocortisone
1. Xerese patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| USRE39264 | BAUSCH | Pharmaceutical combination |
Aug, 2016
(7 years ago) | |
| US6514980 | BAUSCH | Nucleoside analogs in combination therapy of herpes simplex infections |
Jul, 2018
(5 years ago) | |
| US7223387 | BAUSCH | Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester |
Nov, 2022
(1 year, 5 months ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Patient Population(NPP) | Jan 22, 2017 |
| New Combination(NC) | Jul 31, 2012 |
Market Authorisation Date: 31 July, 2009
Treatment: New combination product for the early treatment of recurrent herpes labialis (cold sores) to reduce the likelihood of ulcerative cold sores and to shorten the lesion healing time in adults and adolesc...
Dosage: CREAM;TOPICAL
More Information on Dosage
XERESE family patents
